American Heart Journal
Volume 144, Issue 5 , Pages 760-768 , November 2002

A meta-analysis of the angiotensin-converting enzyme gene polymorphism and restenosis after percutaneous transluminal coronary revascularization: Evidence for publication bias

Received 16 July 2001 ,Accepted 11 January 2002.

References 

  1. Thyberg J, Hedin U, Sjolund M, et al.  Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis. 1990;10:966–990
  2. Cambien F, Poirier O, Lecerf L, et al.  Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641–644
  3. Tiret L, Rigat B, Visvikis S, et al.  Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 1992;51:197–205
  4. Costerousse O, Allegrini J, Lopez M, et al.  Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J. 1993;290:33–40
  5. Bauters C, Amouyel P. Association between the ACE genotype and coronary artery disease: insights from studies on restenosis, vasomotion and thrombosis. Eur Heart J. 1998;19(J Suppl):J24–J29
  6. Bauters C, Amouyel P, Bertrand ME. ACE gene polymorphism and coronary restenosis. Semin Interv Cardiol. 1999;4:145–149
  7. Nobuyoshi M, Kimura T, Nosaka H, et al.  Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol. 1988;12:616–623
  8. Serruys PW, Luijten HE, Beatt KJ, et al.  Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon: a quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation. 1988;77:361–371
  9. Walter SD, Cook RJ. A comparison of several point estimators of the odds ratio in a single 2 × 2 contingency table. Biometrics. 1991;47:795–811
  10. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188
  11. Egger M, Smith GD. Bias in location and selection of studies. BMJ. 1998;316:61–66
  12. Gensini F, Battaglini B, Fatini C, et al.  Polimorfismo I/D del gene ACE e A1166C del gene AT1R quali fattori di rischio di restenosi dopo angioplastica coronarica. Minerva Cardioangiol. 1999;47:516
  13. Guarda E, Fajuri A, Marchant E, et al.  El genotipo D/D del gen de la enzima conversiva de la angiotensina como factor de riesgo de reestenosis post-stent coronario. Rev Esp Cardiol. 1999;52:475–480
  14. Haberbosch W, Bohle RM, Franke FE, et al.  The expression of angiotensin-I converting enzyme in human atherosclerotic plaques is not related to the deletion/insertion polymorphism but to the risk of restenosis after coronary interventions. Atherosclerosis. 1997;130:203–213
  15. Hamon M, Bauters C, Amant C, et al.  Relation between the deletion polymorphism of the angiotensin-converting enzyme gene and late luminal narrowing after coronary angioplasty. Circulation. 1995;92:296–299
  16. Hamon M, Amant C, Bauters C, et al.  ACE polymorphism, a genetic predictor of occlusion after coronary angioplasty. Am J Cardiol. 1996;78:679–681
  17. Hamon M, Amant C, Bauters C, et al.  Dual determination of angiotensin-converting enzyme and angiotensin-II type 1 receptor genotypes as predictors of restenosis after coronary angioplasty. Am J Cardiol. 1998;81:79–81
  18. Kaski JC, Zhang Y, Calvino R, et al.  Angiotensin-converting enzyme insertion/deletion polymorphism and restenosis after coronary angioplasty in unstable angina pectoris. Am J Cardiol. 1996;77:875–877
  19. Koch W, Kastrati A, Mehilli J, et al.  Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement. Circulation. 2000;102:197–202
  20. Ohishi M, Fujii K, Minamino T, et al.  A potent genetic risk factor for restenosis [letter]. Nat Genet. 1993;5:324–325
  21. Ribichini F, Steffenino G, Dellavalle A, et al.  Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme: a major risk factor and a marker of risk for coronary stent restenosis. Circulation. 1998;97:147–154
  22. Samani NJ, Martin DS, Brack M, et al.  Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty. Lancet. 1995;345:1013–1016
  23. van Bockxmeer FM, Mamotte CD, Gibbons FA, et al.  Angiotensin-converting enzyme and apolipoprotein E genotypes and restenosis after coronary angioplasty. Circulation. 1995;92:2066–2071
  24. Kastrati A, Dirschinger J, Schomig A. Genetic risk factors and restenosis after percutaneous coronary interventions. Herz. 2000;25:34–46
  25. Kaski JC. Are polymorphisms in the ACE gene a potent genetic risk factor for restenosis?. Br Heart J. 1994;72:101
  26. Cesari M, Rossi GP. Il polimorfismo I/D del gene dell'ACE: marker di rischio cardiovascolare o “abbaglio” della genetica molecolare?. G Ital Cardiol. 1997;27:1044–1052
  27. Galve E. Implantacion de stent coronario y reestenosis. Puede predecirse examinando los genes?. Rev Esp Cardiol. 1999;52:481–484
  28. Jukema JW. Matching treatment to the genetic basis of (lipid) disorder in patients with coronary artery disease. Heart. 1999;82:126–127
  29. Amant C, Bauters C, Bodart JC, et al.  D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation. 1997;96:56–60
  30. Beohar N, Damaraju S, Prather A, et al.  Angiotensin-I converting enzyme genotype DD is a risk factor for coronary artery disease. J Invest Med. 1995;43:275–280
  31. Rauchhaus M, Francis DP, Schmidt H, et al.  Not the ACE gene polymorphism, but the E-selectin gene polymorphism helps to predict restenosis after coronary angioplasty [abstract]. Circulation. 1998;98(Suppl):I393
  32. Moussard C, Vuillemenot A, Schiele F, et al.  Polymorphisms in the angiotensin I-converting enzyme and apolipoprotein E genes and late luminal narrowing after coronary angioplasty in men [abstract]. J Am Coll Cardiol. 1996;27(Suppl):244A
  33. Suzuki M, Ogasawara K, Aizawa T, et al.  Angiotensin-converting enzyme insertion/deletion polymorphism and restenosis after directional coronary athrectomy [abstract]. Circulation. 1997;96(Suppl):I650
  34. Windecker S, Maier RW, Bonzel T, et al.  Interventional cardiology in Europe 1995. Eur Heart J. 1999;20:484–495
  35. Van Houwelingen HC, Zwinderman KH, Stijnen T. A bivariate approach to meta-analysis. Stat Med. 1993;12:2273–2284
  36. Samani NJ, O'Toole L, Martin D, et al.  Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction. J Am Coll Cardiol. 1996;28:338–344
  37. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet. 1995;11:241–247
  38. Hill AB. Principles of medical statistics. 9 ed. New York (NY): Oxford University Press; 1971;
  39. The MARCATOR study group . Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. J Am Coll Cardiol. 1995;25:362–369
  40. Meurice T, Bauters C, Hermant X, et al.  Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial. Lancet. 2001;357:1321–1324
  41. Morishita R, Gibbons GH, Tomita N, et al.  Antisense oligodeoxynucleotide inhibition of vascular angiotensin-converting enzyme expression attenuates neointimal formation: evidence for tissue angiotensin-converting enzyme function. Arterioscler Thromb Vasc Biol. 2000;20:915–922
  42. Agema WRP, Jukema JW, Pimstone SN, et al.  Genetic aspects of restenosis after percutaneous coronary interventions: towards more tailored therapy. Eur Heart J. 2001;22:2058–2074
  43. Rieder MJ, Taylor SL, Clark AG, et al.  Sequence variation in the human angiotensin converting enzyme. Nat Genet. 1999;22:59–62
  44. Zohlnhofer D, Klein CA, Richter T, et al.  Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy: detection of FK506-binding protein 12 upregulation. Circulation. 2001;103:1396–1402
  45. Petticrew M. Diagoras of Melos (500 BC): an early analyst of publication bias [letter]. Lancet. 1998;352:1558
  46. Samani NJ, Thompson JR, O'Toole L, et al.  A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation. 1996;94:708–712
  47. Venter JC, Adams MD, Myers EW, et al.  The sequence of the human genome. Science. 2001;291:1304–1351
  48. Lander ES, Linton LM, Birren B, et al.  Initial sequencing and analysis of the human genome. Nature. 2001;409:860–921
  49. Chalmers I, Altman DG. How can medical journals help prevent poor medical research? Some opportunities presented by electronic publishing. Lancet. 1999;353:490–493
  50. Horton R. Medical editors trial amnesty. Lancet. 1997;350:756

☆ Supported in part by grant 99.210 from the Netherlands Heart Foundation, and a grant from the Interuniversity Cardiology Institute of the Netherlands.

☆☆ Reprint requests: J. W. Jukema, MD, PhD, FESC, FACC, Leiden University Medical Center, Department of Cardiology, C5-P, PO Box 9600, 2300 RC Leiden, The Netherlands.

★ E-mail: J.W.Jukema@lumc.nl

PII: S0002-8703(02)00183-7

doi: 10.1067/mhj.2002.125509

American Heart Journal
Volume 144, Issue 5 , Pages 760-768 , November 2002

Article Tools

* Image Usage & Resolution